Wesley Bond has a strong background in medical science liaison roles and research. Wesley is currently serving as a Principal Medical Science Liaison at REGENXBIO Inc. Prior to that, they had notable positions at Astellas Gene Therapies and Spark Therapeutics, Inc. where they held roles as a Regional Medical Director and Senior Medical Science Liaison respectively. Wesley also has extensive research experience, having worked as a Postdoctoral Fellow at Vanderbilt University Medical Center, a Postdoctoral Associate at Baylor College of Medicine, and a Postbaccalaureate IRTA Fellow at the National Institutes of Health.
Wesley Bond received a B.S. in Biomedical Engineering from Mississippi State University from 2001 to 2006. From 2007 to 2013, they pursued a Ph.D. in Translational Biology & Molecular Medicine at Baylor College of Medicine.
October, 2022 - present
Vice President Of Chemistry at Xenon Pharmaceuticals
Vp, Medical Affairs, Urology & Critical Care at Becton Dickinson
Principal Scientist at Vesigen Therapeutics
AMSA Global Health Chair 2024 at Australian Medical Students' Association
Senior Director, Head Of Discovery Chemistry at ATAI Life Sciences
Access the worlds's biggest network of public org charts
Learn more